title: Electroconvulsive therapy-induced migraine successfully treated with valproic acid.
abstract: Electroconvulsive therapy (ECT) is mainly used for treating severe depression, mania, schizophrenia, and catatonia. Electroconvulsive therapy is usually without serious adverse effects. Headache is a common complaint after ECT but is usually mild and short lasting. Recurrent common migraine induced by ECT has been rarely reported. We report a patient with ECT-induced migraine successfully treated with valproic acid.
authors.forename: Jörgen M P
authors.initials: JM
authors.lastname: Rovers
authors.forename: Gerwin
authors.initials: G
authors.lastname: Roks
mesh_terms: D000369:Aged, 80 and over; D003865:Major Depressive Disorder / Q000150:complications / Q000628:therapy; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D018682:GABA Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D020325:Migraine with Aura / Q000188:drug therapy* / Q000209:etiology*; D009460:Neurologic Examination; D014202:Tremor / Q000150:complications; D014635:Valproic Acid / Q000627:therapeutic use*; D014717:Vertigo / Q000150:complications / Q000188:drug therapy
chemical_list: D018682:GABA Agents; D014635:Valproic Acid